Lion Biotechnologies (LBIO) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts LBIO Hot Sheet
Join SI Premium – FREE
Lion Biotechnologies (NASDAQ: LBIO) reported Q4 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Lion Biotechnologies (LBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- VNET Group (VNET) Misses Q2 EPS by 164c
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
